{'fraction_non_alphanumeric': 0.028639618138424822, 'fraction_numerical': 0.015513126491646777, 'mean_word_length': 6.232758620689655, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Determination of Gangliosides in Six Human Primary Medulloblastomas

Abstract: The ganglioside composition of six human medulloblastomas was analyzed. The characterization was performed by thin‐layer chromatography, sialidase hydrolysis, and immunological staining with a panel of characterized antiganglioside monoclonal antibodies. The total ganglioside content ranged from 60 to 1,130 nmol of ganglioside sialic acid/g wet weight. Neuronal gangliosides (gangliotetraose series) were found in varying amounts in all medulloblastomas. Gangliosides of the neolactotetraose series (3′‐LM 1 and LD1) were present in all specimens, and the lactotetraose series ganglioside 3′‐isoLM1 was found in all cases showing astro‐cytic differentiation. This supports our previous findings that 3′‐isoLM1 is a marker for proliferating astroglial cells.